BSX vs. ISRG: Boston Scientific vs. Intuitive Surgical Stock Comparison

Company Profile

Boston Scientific (BSX) and Intuitive Surgical (ISRG) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Intuitive Surgical (ISRG) has an aggressive beta of 1.41, indicating higher sensitivity to broad-market moves, while Boston Scientific (BSX) is defensive at 0.57 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Intuitive Surgical (ISRG) at 17.93% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for ISRG.

For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Intuitive Surgical (ISRG) at 25.54% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Boston Scientific (BSX) at 19.05% and Intuitive Surgical (ISRG) at 33.29% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Intuitive Surgical (ISRG) at 20.51% sits in the top revenue growth quartile, while Boston Scientific (BSX) at 19.87% is closer to the peer norm — faster top-line expansion for ISRG.

Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Intuitive Surgical (ISRG) at 22.59% is closer to the peer norm — faster per-share earnings growth for BSX.

Growth Metrics

Financial Strength

Intuitive Surgical (ISRG) at 3.33 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.

Only one side’s leverage can be read here: Boston Scientific (BSX) carries debt-to-equity ratio of 0.46 against its industry range, while Intuitive Surgical (ISRG) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Boston Scientific (BSX) nor Intuitive Surgical (ISRG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Boston Scientific (BSX) nor Intuitive Surgical (ISRG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Intuitive Surgical (ISRG) at 54.75 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

Boston Scientific (BSX) at 2.94 prices around its industry’s typical P/S ratio, while Intuitive Surgical (ISRG) at 13.82 clears its benchmark range — ISRG looks notably rich on sales.

Boston Scientific (BSX) at 2.42 is valued about in line with its industry on P/B ratio, while Intuitive Surgical (ISRG) at 9.82 carries an above-peer premium to book — ISRG is pricier on assets.

Valuation Metrics